
Dyadic International is a biotechnology business based in the US. Dyadic International shares (DYAI) are listed on the NASDAQ and all prices are listed in US Dollars. Dyadic International employs 7 staff and has a trailing 12-month revenue of around $2.5 million.
How to buy Dyadic International stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – DYAI. It's that simple.
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- Get $10 when you sign up and deposit $100
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Dyadic International stock price (NASDAQ: DYAI)
Use our graph to track the performance of DYAI stocks over time.Dyadic International shares at a glance
Latest market close | $1.70 |
---|---|
52-week range | $1.12 - $4.28 |
50-day moving average | $1.53 |
200-day moving average | $2.24 |
Wall St. target price | $7.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.44 |
Buy Dyadic International stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Dyadic International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Dyadic International price performance over time
Historical closes compared with the close of $1.6999 from 2023-01-24
1 week (2023-01-19) | 14.86% |
---|---|
1 month (2022-12-23) | 24.08% |
3 months (2022-10-26) | -20.93% |
6 months (2022-07-26) | -39.72% |
1 year (2022-01-22) | N/A |
---|---|
2 years (2021-01-26) | -69.91% |
3 years (2020-01-24) | 5.22 |
5 years (2018-01-26) | 20.56% |
Dyadic International financials
Revenue TTM | $2.5 million |
---|---|
Gross profit TTM | $459,393 |
Return on assets TTM | -38.69% |
Return on equity TTM | -68.4% |
Profit margin | 0% |
Book value | $0.44 |
Market capitalisation | $44.8 million |
TTM: trailing 12 months
Dyadic International share dividends
We're not expecting Dyadic International to pay a dividend over the next 12 months.
Dyadic International share price volatility
Over the last 12 months, Dyadic International's shares have ranged in value from as little as $1.12 up to $4.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dyadic International's is 0.4527. This would suggest that Dyadic International's shares are less volatile than average (for this exchange).
Dyadic International overview
Dyadic International, Inc. , a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd. ; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S. L.
Dyadic International in the news
Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
Dyadic Announces Sale of Equity Interest in Alphazyme
Frequently asked questions
What percentage of Dyadic International is owned by insiders or institutions?Currently 30.074% of Dyadic International shares are held by insiders and 13.615% by institutions. How many people work for Dyadic International?
Latest data suggests 7 work at Dyadic International. When does the fiscal year end for Dyadic International?
Dyadic International's fiscal year ends in December. Where is Dyadic International based?
Dyadic International's address is: 140 Intracoastal Pointe Drive, Jupiter, FL, United States, 33477-5094 What is Dyadic International's ISIN number?
Dyadic International's international securities identification number is: US26745T1016 What is Dyadic International's CUSIP number?
Dyadic International's Committee on Uniform Securities Identification Procedures number is: 26745T101
More guides on Finder
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
-
Best international stock brokers for 2023
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
Ask an Expert